| Title: | A global real-world study assessing total time to adrenalectomy in primary aldosteronism |
|---|
| Authors: | ID Ter, Charmaine (Author) ID Han Koh, Xuan (Author) ID Tran, Hieu (Author) ID Bancos, Irina (Author) ID Bassiony, Mohamed (Author) ID Araujo-Castro, Marta (Author) ID Paja, Miguel (Author) ID Gonzalez Boillos, Marga (Author) ID Gkaniatsa, Eleftheria (Author) ID Kocjan, Tomaž (Author), et al. |
| Files: | PDF - Presentation file, download (810,84 KB) MD5: 5B5A0026E7BA0DE32EFBA4E53EF65614
URL - Source URL, visit https://academic.oup.com/ejendo/article/193/1/65/8164533
|
|---|
| Language: | English |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: | UKC LJ - Ljubljana University Medical Centre
|
|---|
| Abstract: | Background: Primary aldosteronism (PA) is a common treatable cause of hypertension. When caused by unilateral adrenal disease, it is potentially curable by adrenalectomy. However, specialized tests and other factors may delay definitive treatment. We assessed the time to adrenalectomy (TTA) for patients worldwide. Methods: We conducted an international, multicentre retrospective study involving 39 centres from 15 countries to determine the total time taken from the first presentation to adrenalectomy and the intervals between each stage (screening, confirmatory, subtyping, and adrenalectomy). We included patients with PA who underwent adrenalectomy from January 1, 2018, to October 30, 2022. Post-adrenalectomy outcomes were evaluated using the Primary Aldosteronism Surgery Outcome criteria. We performed multivariable quantile and linear regression to identify characteristics associated with longer TTA. Results: We included 861 patients, mean age 49.3 ± 11.1 years, and 44.5% were women. Overall median TTA was 13.5 months, IQR: 6.6-24.5. Median intervals were 0.1 months (screening), 1.0 months (confirmatory), 4.1 months (subtyping), and 4.3 months (adrenalectomy). On multivariable analysis, median TTA was increased by 5.4 months for each additional adrenal vein sampling (AVS) procedure. Other factors associated with longer TTA included adrenalectomy post-COVID-19, younger age, and additional screening tests. Compared with countries with routine AVS, those without AVS had a shorter TTA (6.1 vs 15.1 months, P < .001), but greater likelihood of absent/partial biochemical success post-adrenalectomy (27.4% vs 12.4%, P < .001). Conclusion: Primary aldosteronism management is time-consuming worldwide, especially for subtyping tests and adrenalectomy. While omitting AVS reduces overall time, patients are less likely to achieve biochemical cure post-adrenalectomy. |
|---|
| Keywords: | adrenal surgery, adrenal vein sampling, primary hyperaldosteronism |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Year of publishing: | 2025 |
|---|
| Number of pages: | str. 65-75 |
|---|
| Numbering: | Vol. 193, iss. 1 |
|---|
| PID: | 20.500.12556/DiRROS-25140  |
|---|
| UDC: | 616.4 |
|---|
| ISSN on article: | 0804-4643 |
|---|
| DOI: | 10.1093/ejendo/lvaf124  |
|---|
| COBISS.SI-ID: | 262424323  |
|---|
| Note: |
|
|---|
| Publication date in DiRROS: | 12.01.2026 |
|---|
| Views: | 119 |
|---|
| Downloads: | 73 |
|---|
| Metadata: |  |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |